Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma

Cancer Cell

Volumn 32, Issue 4, 2017, Pages 520-537.e5

  Mackay, Alan ^a   Burford, Anna ^a   Carvalho, Diana ^a   Izquierdo, Elisa ^a   Fazal Salom, Janat ^a   Taylor, Kathryn R ^a,b   Bjerke, Lynn ^a   Clarke, Matthew ^a   Vinci, Mara ^a   Nandhabalan, Meera ^a   Temelso, Sara ^a   Popov, Sergey ^a,c   Molinari, Valeria ^a   Raman, Pichai ^d   Waanders, Angela J ^d   Han, Harry J ^d   Gupta, Saumya ^e   Marshall, Lynley ^f   Zacharoulis, Stergios ^f   Vaidya, Sucheta ^f   Mandeville, Henry C ^f   Bridges, Leslie R ^g   Martin, Andrew J ^g   Al Sarraj, Safa ^h   Chandler, Christopher ^h   Ng, Ho Keung ⁱ   Li, Xingang ^j   Mu, Kun ^k   Trabelsi, Saoussen ^l   Brahim, Dorra H'mida Ben ^l   Kisljakov, Alexei N ^m   Konovalov, Dmitry M ⁿ   Moore, Andrew S ^o,p   Carcaboso, Angel Montero ^q   Sunol, Mariona ^q   de Torres, Carmen ^q   Cruz, Ofelia ^q   Mora, Jaume ^q   Shats, Ludmila I ^r   Stavale, João N ^s   Bidinotto, Lucas T ^t   Reis, Rui M ^t,u   Entz Werle, Natacha ^v   Farrell, Michael ^w   Cryan, Jane ^w   Crimmins, Darach ^x   Caird, John ^x   Pears, Jane ^y   Monje, Michelle ^b   Debily, Marie Anne ^z   Castel, David ^z   Grill, Jacques ^z   Hawkins, Cynthia ^aa   Nikbakht, Hamid ^ab   Jabado, Nada ^d   Baker, Suzanne J ^ac   Pfister, Stefan M ^ad,ae,aj   Jones, David T W ^ad,aj   Fouladi, Maryam ^af   von Bueren, André O ^ag,ah,ai   Baudis, Michael ^e   Resnick, Adam ^d   Jones, Chris ^a   more..

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f ROYAL MARSDEN HOSPITAL   (United Kingdom)

^g ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^h KING S COLLEGE HOSPITAL   (United Kingdom)

ⁱ CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^j SHANDONG UNIVERSITY   (China)

^k SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^l FARHAT HACHED HOSPITAL   (Tunisia)

^m Morozov Children's Hospital   (Russian Federation)

ⁿ Oncology and Immunology   (Russian Federation)

^o UNIVERSITY OF QUEENSLAND   (Australia)

^p LADY CILENTO CHILDREN S HOSPITAL   (Australia)

^q Fundacion Sant Joan de Deu   (Spain)

^r SAINT PETERSBURG STATE PEDIATRIC MEDICAL UNIVERSITY   (Russian Federation)

^s FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^t BARRETOS CANCER HOSPITAL   (Brazil)

^u UNIVERSITY OF MINHO   (Portugal)

^v UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^w BEAUMONT HOSPITAL   (Ireland)

^x CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

^y OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^z INSTITUT GUSTAVE ROUSSY   (France)

^aa HOSPITAL FOR SICK CHILDREN   (Canada)

^ab MCGILL UNIVERSITY   (Canada)

^ac ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^ad GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ae UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^af CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^ag UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^ah GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^ai UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^aj Preclinical Program   (Germany)

more..

Author keywords

DIPG; exome; genome; glioblastoma; histone; methylation

Indexed keywords

HISTONE; HISTONE H3; ISOCITRATE DEHYDROGENASE 1; BCOR PROTEIN, HUMAN; CELL CYCLE PROTEIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE III; F BOX PROTEIN; FBXW7 PROTEIN, HUMAN; ONCOPROTEIN; REPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; GLIOMA; HUMAN; META ANALYSIS; METHYLATION; MUTATION; PONTINE GLIOMA; PRIORITY JOURNAL; WHOLE EXOME SEQUENCING; WHOLE GENOME SEQUENCING; WILD TYPE; ADOLESCENT; BRAIN STEM TUMOR; CHILD; EXOME; FEMALE; GENE DOSAGE; GENETICS; INFANT; MALE; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; BRAIN STEM NEOPLASMS; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; DNA TOPOISOMERASES, TYPE I; EXOME; F-BOX PROTEINS; FEMALE; GENE DOSAGE; GLIOMA; HISTONES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUTATION; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; YOUNG ADULT;

EID: 85030706440     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2017.08.017     Document Type: Article

References (55)

1. Baker, S.J., Ellison, D.W., Gutmann, D.H., Pediatric gliomas as neurodevelopmental disorders. Glia 64 (2015), 879–895.
2. Barrow, J., Adamowicz-Brice, M., Cartmill, M., MacArthur, D., Lowe, J., Robson, K., Brundler, M.A., Walker, D.A., Coyle, B., Grundy, R., Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas. Neuro Oncol. 13 (2011), 212–222.
3. Bax, D.A., Mackay, A., Little, S.E., Carvalho, D., Viana-Pereira, M., Tamber, N., Grigoriadis, A.E., Ashworth, A., Reis, R.M., Ellison, D.W., et al. A distinct spectrum of copy number aberrations in pediatric high-grade gliomas. Clin. Cancer Res. 16 (2010), 3368–3377.
4. Bender, S., Tang, Y., Lindroth, A.M., Hovestadt, V., Jones, D.T., Kool, M., Zapatka, M., Northcott, P.A., Sturm, D., Wang, W., et al. Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell 24 (2013), 660–672.
5. Bjerke, L., Mackay, A., Nandhabalan, M., Burford, A., Jury, A., Popov, S., Bax, D.A., Carvalho, D., Taylor, K.R., Vinci, M., et al. Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCN. Cancer Discov. 3 (2013), 512–519.
6. Bouffet, E., Larouche, V., Campbell, B.B., Merico, D., de Borja, R., Aronson, M., Durno, C., Krueger, J., Cabric, V., Ramaswamy, V., et al. Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency. J. Clin. Oncol., 34, 2016, 2206.
7. Buczkowicz, P., Hoeman, C., Rakopoulos, P., Pajovic, S., Letourneau, L., Dzamba, M., Morrison, A., Lewis, P., Bouffet, E., Bartels, U., et al. Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat. Genet. 46 (2014), 451–456.
8. Cai, H., Kumar, N., Baudis, M., arrayMap: a reference resource for genomic copy number imbalances in human malignancies. PLoS One, 7, 2012, e36944.
9. Cai, H., Kumar, N., Ai, N., Gupta, S., Rath, P., Baudis, M., Progenetix: 12 years of oncogenomic data curation. Nucleic Acids Res. 42 (2014), D1055–D1062.
10. Carvalho, D., Mackay, A., Bjerke, L., Grundy, R.G., Lopes, C., Reis, R.M., Jones, C., The prognostic role of intragenic copy number breakpoints and identification of novel fusion genes in paediatric high grade glioma. Acta Neuropathol. Commun., 2, 2014, 23.
11. Castel, D., Philippe, C., Calmon, R., Le Dret, L., Truffaux, N., Boddaert, N., Pages, M., Taylor, K.R., Saulnier, P., Lacroix, L., et al. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol. 130 (2015), 815–827.
12. Ceccarelli, M., Barthel, F.P., Malta, T.M., Sabedot, T.S., Salama, S.R., Murray, B.A., Morozova, O., Newton, Y., Radenbaugh, A., Pagnotta, S.M., et al. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164 (2016), 550–563.
13. Chan, K.M., Fang, D., Gan, H., Hashizume, R., Yu, C., Schroeder, M., Gupta, N., Mueller, S., James, C.D., Jenkins, R., et al. The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev. 27 (2013), 985–990.
14. Davis, R.J., Welcker, M., Clurman, B.E., Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities. Cancer Cell 26 (2014), 455–464.
15. Fontebasso, A.M., Schwartzentruber, J., Khuong-Quang, D.A., Liu, X.Y., Sturm, D., Korshunov, A., Jones, D.T., Witt, H., Kool, M., Albrecht, S., et al. Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas. Acta Neuropathol. 125 (2013), 659–669.
16. Fontebasso, A.M., Papillon-Cavanagh, S., Schwartzentruber, J., Nikbakht, H., Gerges, N., Fiset, P.O., Bechet, D., Faury, D., De Jay, N., Ramkissoon, L.A., et al. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat. Genet. 46 (2014), 462–466.
17. Funato, K., Major, T., Lewis, P.W., Allis, C.D., Tabar, V., Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation. Science 346 (2014), 1529–1533.
18. Grasso, C.S., Tang, Y., Truffaux, N., Berlow, N.E., Liu, L., Debily, M.A., Quist, M.J., Davis, L.E., Huang, E.C., Woo, P.J., et al. Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat. Med. 21 (2015), 555–559.
19. Hennika, T., Hu, G., Olaciregui, N.G., Barton, K.L., Ehteda, A., Chitranjan, A., Chang, C., Gifford, A.J., Tsoli, M., Ziegler, D.S., et al. Pre-clinical study of panobinostat in xenograft and genetically engineered murine diffuse intrinsic pontine glioma models. PLoS One, 12, 2017, e0169485.
20. International Cancer Genome Consortium PedBrain Tumor Project. Recurrent MET fusion genes represent a drug target in pediatric glioblastoma. Nat. Med. 22 (2016), 1314–1320.
21. Jones, C., Baker, S.J., Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma. Nat. Rev. Cancer 14 (2014), 651–661.
22. Jones, C., Perryman, L., Hargrave, D., Paediatric and adult malignant glioma: close relatives or distant cousins?. Nat. Rev. Clin. Oncol. 9 (2012), 400–413.
23. Jones, C., Karajannis, M.A., Jones, D.T., Kieran, M.W., Monje, M., Baker, S.J., Becher, O.J., Cho, Y.J., Gupta, N., Hawkins, C., et al. Pediatric high-grade glioma: biologically and clinically in need of new thinking. Neuro Oncol., 19, 2016, 153.
24. Khuong-Quang, D.A., Buczkowicz, P., Rakopoulos, P., Liu, X.Y., Fontebasso, A.M., Bouffet, E., Bartels, U., Albrecht, S., Schwartzentruber, J., Letourneau, L., et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol. 124 (2012), 439–447.
25. Korshunov, A., Ryzhova, M., Hovestadt, V., Bender, S., Sturm, D., Capper, D., Meyer, J., Schrimpf, D., Kool, M., Northcott, P.A., et al. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Acta Neuropathol. 129 (2015), 669–678.
26. Korshunov, A., Schrimpf, D., Ryzhova, M., Sturm, D., Chavez, L., Hovestadt, V., Sharma, T., Habel, A., Burford, A., Jones, C., et al. H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers. Acta Neuropathol., 2017, 10.1007/s00401-017-1710-1.
27. Kramm, C.M., Butenhoff, S., Rausche, U., Warmuth-Metz, M., Kortmann, R.D., Pietsch, T., Gnekow, A., Jorch, N., Janssen, G., Berthold, F., et al. Thalamic high-grade gliomas in children: a distinct clinical subset?. Neuro Oncol. 13 (2011), 680–689.
28. Louis, D.N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W.K., Ohgaki, H., Wiestler, O.D., Kleihues, P., Ellison, D.W., The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131 (2016), 803–820.
29. Nicolaides, T.P., Li, H., Solomon, D.A., Hariono, S., Hashizume, R., Barkovich, K., Baker, S.J., Paugh, B.S., Jones, C., Forshew, T., et al. Targeted therapy for BRAFV600E malignant astrocytoma. Clin. Cancer Res. 17 (2011), 7595–7604.
30. Northcott, P.A., Lee, C., Zichner, T., Stutz, A.M., Erkek, S., Kawauchi, D., Shih, D.J., Hovestadt, V., Zapatka, M., Sturm, D., et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature 511 (2014), 428–434.
31. Ostrom, Q.T., Gittleman, H., Fulop, J., Liu, M., Blanda, R., Kromer, C., Wolinsky, Y., Kruchko, C., Barnholtz-Sloan, J.S., CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol. 17:Suppl 4 (2015), iv1–iv62.
32. Paugh, B.S., Qu, C., Jones, C., Liu, Z., Adamowicz-Brice, M., Zhang, J., Bax, D.A., Coyle, B., Barrow, J., Hargrave, D., et al. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J. Clin. Oncol. 28 (2010), 3061–3068.
33. Paugh, B.S., Broniscer, A., Qu, C., Miller, C.P., Zhang, J., Tatevossian, R.G., Olson, J.M., Geyer, J.R., Chi, S.N., da Silva, N.S., et al. Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J. Clin. Oncol. 29 (2011), 3999–4006.
34. Paugh, B.S., Zhu, X., Qu, C., Endersby, R., Diaz, A.K., Zhang, J., Bax, D.A., Carvalho, D., Reis, R.M., Onar-Thomas, A., et al. Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Res. 73 (2013), 6219–6229.
35. Puget, S., Philippe, C., Bax, D.A., Job, B., Varlet, P., Junier, M.P., Andreiuolo, F., Carvalho, D., Reis, R., Guerrini-Rousseau, L., et al. Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS One, 7, 2012, e30313.
36. Qin, E.Y., Cooper, D.D., Abbott, K.L., Lennon, J., Nagaraja, S., Mackay, A., Jones, C., Vogel, H., Jackson, P.K., Monje, M., Neural Precursor-Derived Pleiotrophin Mediates Subventricular Zone Invasion by Glioma. Cell 170:5 (2017), 845–859.
37. Richards, M.W., Burgess, S.G., Poon, E., Carstensen, A., Eilers, M., Chesler, L., Bayliss, R., Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors. Proc. Natl. Acad. Sci. USA 113 (2016), 13726–13731.
38. Schiffman, J.D., Hodgson, J.G., VandenBerg, S.R., Flaherty, P., Polley, M.Y., Yu, M., Fisher, P.G., Rowitch, D.H., Ford, J.M., Berger, M.S., et al. Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. Cancer Res. 70 (2010), 512–519.
39. Schwartzentruber, J., Korshunov, A., Liu, X.Y., Jones, D.T., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A.M., Quang, D.A., Tonjes, M., et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482 (2012), 226–231.
40. Shlien, A., Campbell, B.B., de Borja, R., Alexandrov, L.B., Merico, D., Wedge, D., Van Loo, P., Tarpey, P.S., Coupland, P., Behjati, S., et al. Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers. Nat. Genet. 47 (2015), 257–262.
41. Sturm, D., Witt, H., Hovestadt, V., Khuong-Quang, D.A., Jones, D.T., Konermann, C., Pfaff, E., Tonjes, M., Sill, M., Bender, S., et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22 (2012), 425–437.
42. Sturm, D., Bender, S., Jones, D.T., Lichter, P., Grill, J., Becher, O., Hawkins, C., Majewski, J., Jones, C., Costello, J.F., et al. Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat. Rev. Cancer 14 (2014), 92–107.
43. Taylor, K.R., Mackay, A., Truffaux, N., Butterfield, Y.S., Morozova, O., Philippe, C., Castel, D., Grasso, C.S., Vinci, M., Carvalho, D., et al. Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat. Genet. 46 (2014), 457–461.
44. Taylor, K.R., Vinci, M., Bullock, A.N., Jones, C., ACVR1 mutations in DIPG: lessons learned from FOP. Cancer Res. 74 (2014), 4565–4570.
45. Temime-Smaali, N., Guittat, L., Wenner, T., Bayart, E., Douarre, C., Gomez, D., Giraud-Panis, M.J., Londono-Vallejo, A., Gilson, E., Amor-Gueret, M., et al. Topoisomerase IIIalpha is required for normal proliferation and telomere stability in alternative lengthening of telomeres. EMBO J. 27 (2008), 1513–1524.
46. Temime-Smaali, N., Guittat, L., Sidibe, A., Shin-ya, K., Trentesaux, C., Riou, J.F., The G-quadruplex ligand telomestatin impairs binding of topoisomerase IIIalpha to G-quadruplex-forming oligonucleotides and uncaps telomeres in ALT cells. PLoS One, 4, 2009, e6919.
47. Tiberi, L., Bonnefont, J., van den Ameele, J., Le Bon, S.D., Herpoel, A., Bilheu, A., Baron, B.W., Vanderhaeghen, P., A BCL6/BCOR/SIRT1 complex triggers neurogenesis and suppresses medulloblastoma by repressing Sonic Hedgehog signaling. Cancer Cell 26 (2014), 797–812.
48. Venkatesh, H.S., Johung, T.B., Caretti, V., Noll, A., Tang, Y., Nagaraja, S., Gibson, E.M., Mount, C.W., Polepalli, J., Mitra, S.S., et al. Neuronal activity promotes glioma growth through Neuroligin-3 secretion. Cell 161 (2015), 803–816.
49. Welcker, M., Orian, A., Jin, J., Grim, J.E., Harper, J.W., Eisenman, R.N., Clurman, B.E., The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl. Acad. Sci. USA 101 (2004), 9085–9090.
50. Wu, L., Davies, S.L., North, P.S., Goulaouic, H., Riou, J.F., Turley, H., Gatter, K.C., Hickson, I.D., The Bloom's syndrome gene product interacts with topoisomerase III. J. Biol. Chem. 275 (2000), 9636–9644.
51. Wu, G., Broniscer, A., McEachron, T.A., Lu, C., Paugh, B.S., Becksfort, J., Qu, C., Ding, L., Huether, R., Parker, M., et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet. 44 (2012), 251–253.
52. Wu, G., Diaz, A.K., Paugh, B.S., Rankin, S.L., Ju, B., Li, Y., Zhu, X., Qu, C., Chen, X., Zhang, J., et al. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat. Genet. 46 (2014), 444–450.
53. Yada, M., Hatakeyama, S., Kamura, T., Nishiyama, M., Tsunematsu, R., Imaki, H., Ishida, N., Okumura, F., Nakayama, K., Nakayama, K.I., Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 23 (2004), 2116–2125.
54. Yang, J., Bachrati, C.Z., Ou, J., Hickson, I.D., Brown, G.W., Human topoisomerase IIIalpha is a single-stranded DNA decatenase that is stimulated by BLM and RMI1. J. Biol. Chem. 285 (2010), 21426–21436.
55. Zarghooni, M., Bartels, U., Lee, E., Buczkowicz, P., Morrison, A., Huang, A., Bouffet, E., Hawkins, C., Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets. J. Clin. Oncol. 28 (2010), 1337–1344.